Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Clinical Trial Packaging and Labelling Market Report 2023-2033
... understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Number of Clinical ... Read More
-
Chemotherapy induced diarrhea - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the CID market trends in the United States, EU4 and the UK and Japan. The Chemotherapy-induced Diarrhea (CID) market report provides current treatment practices, emerging drugs, CID market share of ... Read More
-
Idiopathic Inflammatory Myopathies
... market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential ... Read More
-
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
... a defect in insulin secretion and sensitivity, whereby the β-cells in the pancreas fail to secrete sufficient amounts of insulin and cells fail to uptake adequate amounts of insulin due to loss of sensitivity, commonly ... Read More
-
B-Cell Non-Hodgkins Lymphoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and China) for marketed and pipeline therapies with established mechanisms of action by class, including early to ... Read More
-
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 26.9 million diagnosed incidence cases of SIT are expected across 16 pharmaceutical markets. Roche’s Xofluza (baloxavir) was the most recent entry to the influenza market. The influenza pipeline consists of 108 pharmaceutical therapies spanning ... Read More
-
Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Liver Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Peripheral Artery Occlusive Disease (PAOD) Clinical trials scenario. This report provides ... Read More
-
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Non Alcoholic Fatty Liver Disease (NAFLD) Clinical trials scenario. ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 180,000 diagnosed prevalent cases of CIDP across 16 pharmaceutical markets. The majority of marketed drugs for the treatment of CIDP fall into the human immunoglobulins category. There are only six ... Read More
-
Rhinosinusitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Rhinosinusitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Rhinosinusitis. Report includes ... Read More
-
Pulmonary Arterial Hypertension Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Pulmonary Arterial Hypertension Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Influenzavirus B Infections Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 1.3 billion total prevalent cases of NAFLD across 16 pharmaceutical markets. Currently, there are no FDA or EMA approved drugs for NAFLD. The NAFLD pipeline consists of 145 pharmaceuticals spanning ... Read More
-
Dry Eye Syndrome Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2018-2028
... is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics ... Read More
-
Colorectal Cancer Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment by ... Read More
-
Impact of Brazil on the Pharmaceutical Industry - Thematic Intelligence
... contract manufacturing, market access, and key players Brazil has the largest pharma market in Central/Southern America and is the 12th largest pharmaceutical market in the world, with the 2022 election results likely to boost the ... Read More
-
Growth Opportunities and Innovative Use Cases for AI in Clinical Trials
... design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs. The rapid adoption of AI/ML algorithms and platforms to structure and utilize electronic ... Read More
-
Global Clinical Trial Biorepository and Archiving Solutions Market 2022-2028
... at a CAGR of almost 7.8% during the forecast period 2022-2028. The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global clinical trial biorepository and archiving solutions market. ... Read More
-
Endometriosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
... such as oral contraceptives and NSAIDs, which provide affordable options with limited side effects. These factors create a stiff barrier for entry of novel therapeutics, but pipeline therapeutics will find success due to strong efficacy ... Read More
-
Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... 10-year patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment ... Read More
-
2023 Global Forecast for Clinical Trial Management System Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
-
2023 Global Forecast for Cognitive Assessment And Training Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
-
2023 Global Forecast for Biosimulation Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales (product shipments ... Read More
-
2023 Global Forecast for Clinical Trial Supplies Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
Research Assistance
